CDH1 and non-small cell lung carcinoma: Reports suggested that NLK overexpression can inhibit the occurrence of EMT and subsequently inhibit the proliferation and migration of non-small cell lung cancer (NSCLC) by affecting E-cadherin protein expression [34, 35].